Kristin Thompson is Vice President, head of BD at eureKare, a private investment company focused on microbiome and synthetic biology.  Kristin holds a degree in Biology from the University of North Carolina-Chapel Hill and a doctorate in Molecular Medicine from the University of Ulm, Germany.  Kristin worked for more than 10 years as a researcher on projects in genetics, physiology and molecular biology for UNC-CH, Inserm in France, PTC Therapeutics and Boehringer Ingelheim.  Kristin then transitioned to roles in Business Development, including in-and out licensing at the microbiome company, Da Volterra in Paris, France and as Senior Business Developer focusing on R&D and innovation with Famar. During her time managing Strategic Partnerships at Bioaster in Lyon, Kristin was also a coach for MBA students at the HEC to advise on creation of biotechs and how to build a partnering strategy. She is often consulted for strategic insights in the life science sector.